Evidence map›Paper›PMID 39104016›Full record

ArticleJournal of clinical periodontology2024

Salivary and serum inflammatory biomarkers during periodontitis progression and after treatment.

Flavia R F Teles, Ganesh Chandrasekaran, Lynn Martin, Michele Patel, Michael J Kallan, Camila Furquim, Tahir Hamza, Andrew J Cucchiara, Alpdogan Kantarci, Olivia Urquhart and 2 more

Abstract read
In one paragraph

Article in Journal of clinical periodontology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Flavia R F TelesDepartment of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-6945-9811
Ganesh ChandrasekaranDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lynn MartinDepartment of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Michele PatelMultiplex Core, The Forsyth Institute, Cambridge, Massachusetts, USA.
Michael J KallanCenter for Clinical Epidemiology and Biostatistics (CCEB), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Camila FurquimDepartment of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-9370-3156
Tahir HamzaDepartment of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Andrew J CucchiaraCenter for Clinical Epidemiology and Biostatistics (CCEB), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Alpdogan KantarciMultiplex Core, The Forsyth Institute, Cambridge, Massachusetts, USA.ORCID 0000-0002-2679-9100
Olivia UrquhartDepartment of Preventive and Restorative Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-0517-1266
James SugaiDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
William V GiannobileDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-7102-9746

Funding

Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4M
Biomarkers of Periodontal Disease ProgressionU01DE021127 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI TELES, RICARDO P · 2010 to 2016
$16.2M
Defining Dysbiosis and Mechanisms of Periodontitis Progression and StabilityR01DE033033 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI Kyle Bittinger, Flavia Rocha Teles · 2024 to 2026
$1.8M
Center for Human Phenomic Science (CHPS) CTSA 2UL1TR001878-06Childrens' Hospital of Philadelphia (CHOP) Microbiome Pilot AwardNational Center for Advancing Translational Sciences of the National Institutes of Health UL1TR001878NCATS NIH HHS UL1 TR001878NIDCR NIH HHS DE021127-01NIDCR NIH HHS R01 DE033033NIDCR NIH HHS R01DE033033-01A1NIDCR NIH HHS U01 DE021127
6 · The paper itself

Abstract

aimTo identify serum- and salivary-derived inflammatory biomarkers of periodontitis progression and determine their response to non-surgical treatment. MATERIALS AND

methodsPeriodontally healthy (H; n = 113) and periodontitis patients (P; n = 302) were monitored bi-monthly for 1 year without therapy. Periodontitis patients were re-examined 6 months after non-surgical periodontal therapy (NSPT). Participants were classified according to disease progression: P0 (no sites progressed; P1: 1-2 sites progressed; P2: 3 or more sites progressed). Ten salivary and five serum biomarkers were measured using Luminex. Log-transformed levels were compared over time according to baseline diagnosis, progression trajectory and after NSPT. Significant differences were sought using linear mixed models.

resultsP2 presented higher levels (p < .05) of salivary IFNγ, IL-6, VEGF, IL-1β, MMP-8, IL-10 and OPG over time. Serum analytes were not associated with progression. NSPT led to clinical improvement and significant reduction of IFNγ, IL-6, IL-8, IL-1β, MMP-8, IL-10, OPG and MMP-9 in saliva and of CRP, MMP-8, MMP-9 and MPO in serum.

conclusionsPeriodontitis progression results from a sustained pro-inflammatory milieu that is reflected in salivary biomarkers, but less so in serum, likely because of the limited amount of progression per patient. NSPT can significantly decrease the levels of several salivary analytes.

Indexed as

BiomarkersDisease ProgressionInterferon-gammaInterleukin-10Matrix Metalloproteinase 8Matrix Metalloproteinase 9PeriodontitisSalivaVascular Endothelial Growth Factor AAdultC-Reactive ProteinFemaleHumansInterleukin-1betaInterleukin-6Interleukin-8BiomarkersC-Reactive ProteinIL10 protein, humanIL6 protein, humanInterferon-gammaInterleukin-10Interleukin-1betaInterleukin-6Interleukin-8Matrix Metalloproteinase 8Matrix Metalloproteinase 9MMP8 protein, humanMMP9 protein, humanOsteoprotegerinVascular Endothelial Growth Factor AVEGFA protein, humandiagnosisimmunologypathogenesisperiodontal diseases

Identifiers

PMID39104016
PMCPMC11651721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.